Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths—around 1.8 million lives lost each year. One of the main reasons is late ...
The connection between smoking cigarettes and lung cancer risk has been clear for decades — but what about marijuana? As more U.S. states legalize recreational cannabis, new and developing research ...
PUEBLO, Colo. (KOAA) — UCHealth Parkview has announced that it's expanding access to advanced lung diagnostics in southern Colorado with the Ion robotic bronchoscopy system, a technology that allows ...
Clinical Trial Patient Matching: A Real-Time, Common Data Model and Artificial Intelligence–Driven System for Semiautomated Patient Prescreening in Cancer Clinical Trials We developed an eXtreme ...
Sponsored and provided by LifeBridge Health. Dr. Joseph Bennett is the System Chief of Surgery with LifeBridge Health. In this ASK A DOC, Dr. Bennett talks about the new Ion Robotic-Assisted ...
LMH Health, 325 Maine St., is pictured in May 2021. “The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects. Lung cancer is one of the ...
bioAffinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung ...
ASCO guidance for stage IV EGFR-mutant NSCLC supports initial combination regimens (osimertinib plus chemotherapy; amivantamab plus lazertinib) to improve disease control relative to monotherapy.
A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...
©2026 FOX News Network, LLC. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. All market data delayed 20 minutes.
Many eligible patients miss lung cancer screening due to low awareness and systemic barriers, putting underserved groups at higher risk for late-stage disease. She also explained the differences in ...
A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results